Niagen Bioscience (NASDAQ:NAGE) Downgraded to “Buy” Rating by Wall Street Zen
Wall Street Zen lowered shares of Niagen Bioscience (NASDAQ:NAGE – Free Report) from a strong-buy rating to a buy rating in a research report sent to investors on Tuesday morning. Other equities analysts have also issued reports about the stock. HC Wainwright boosted their price objective on shares of Niagen Bioscience from $11.00 to $12.00 […]
More Stories
Trump Says US Control of Greenland Would Make NATO Stronger
By Tom Ozimek President Donald Trump said on Jan. 14 that NATO would be a stronger and more credible deterrent...
Constraining Mega-Landlords Would Help Some Buyers, Won’t Solve Housing Woes: Industry Insiders
By Petr Svab President Donald Trump’s proposed ban on large corporate landlords buying more single-family homes could help families looking...
DHS Calls on Minnesota to Honor ICE Arrest Detainers of More Than 1,360 Criminal Illegal Aliens
By Naveen Athrappully The U.S. Department of Homeland Security (DHS) called on Governor Tim Walz and Minneapolis Mayor Jacob Frey...
Greenlandic, Danish Ministers to Meet With Vance, Rubio in Washington: Rasmussen
By Victor Friedman Danish Foreign Minister Lars Lokke Rasmussen said that he and his Greenlandic counterpart, Vivian Motzfeldt, will meet...
Minnesota Stealing: Reason to Rethink Government Welfare
By Larry Elder As for the estimated $8 billion in government (taxpayer) money stolen by crooks in Minnesota, people demand...
Trump Says Minnesota Officials Will Face ‘Day of Reckoning’ Amid Protests
By Jack Phillips President Donald Trump on Tuesday warned that state officials in Minnesota would face a “DAY OF RECKONING...